Section 34-20B-20 - Depressants specifically included in Schedule IIIAny material, compound, mixture, or preparation is included in Schedule III that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:
(1) Any substance that contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances that are specifically listed in other schedules;(8) Sulfondiethylmethane;(11) Amobarbital, pentobarbital, and secobarbital in suppository dosage form;(12) Gamma hydroxy butyrate;(13) Dronabinol in sesame oil and encapsulated in a gelatin capsule in a drug product approved for marketing by the United States Food and Drug Administration;(16) Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl) benzonitrile], including its salts, isomers, and salts of isomers.SL 1970, ch 229, § 8 (c) (1); SDCL Supp, § 39-17-63; SL 1973, ch 260; SL 1979, ch 238, § 2; SL 1980, ch 240, § 1; SL 1992, ch 245, § 2; SL 1993, ch 247, § 4; SL 1999, ch 174, §1; SL 2000, ch 170, §2; SL 2003, ch 183, §3; SL 2007, ch 194, §2, eff. Feb. 1, 2007; SL 2014, ch 165, §2, eff. Feb. 10, 2014; SL 2018, ch 203, §4, eff. Feb. 8, 2018.Amended by S.L. 2018, ch. 203,s. 4, eff. 2/8/2018.Amended by S.L. 2014, ch. 165,s. 2, eff. 2/10/2014.